Structures by: Saber A.
Total: 7
1-Benzyl-3-[(1-benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one monohydrate
C24H21N5O,H2O
Acta Crystallographica Section E (2020) 76, 1 95-101
a=9.0872(2)Å b=21.1012(4)Å c=11.7134(2)Å
α=90° β=112.6540(10)° γ=90°
1-Methyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C11H10N2O
Acta Crystallographica Section E (2019) 75, 12 1940-1946
a=7.1507(3)Å b=8.8177(4)Å c=15.4602(7)Å
α=90° β=97.914(2)° γ=90°
1-Benzyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C17H14N2O
Acta Crystallographica Section E (2018) 74, 12 1842-1846
a=8.3567(2)Å b=9.2040(2)Å c=17.7868(4)Å
α=90° β=94.5590(10)° γ=90°
1-{[2-Oxo-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-1-yl)methyl}-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C21H20N4O2
Acta Crystallographica Section E (2018) 74, 12 1746-1750
a=11.5244(5)Å b=8.6312(4)Å c=17.9845(8)Å
α=90° β=94.1340(10)° γ=90°
3,4-Dimethyl-1<i>H</i>-1,2,4-triazepino[2,3-<i>a</i>]benzimidazol- 2(3<i>H</i>)-one
C12H12N4O
Acta Crystallographica Section E (2010) 66, 5 o1093
a=7.2899(3)Å b=14.4888(5)Å c=10.9932(4)Å
α=90.00° β=104.3140(10)° γ=90.00°
1-Isopropenyl-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one
C10H10N2O
Acta Crystallographica Section E (2010) 66, 6 o1409
a=15.8724(2)Å b=6.09710(10)Å c=17.9313(3)Å
α=90.00° β=90.961(2)° γ=90.00°
4-Methyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one monohydrate
C10H10N2O,H2O
Acta Crystallographica Section E (2010) 66, 6 o1408
a=4.90130(10)Å b=7.31480(10)Å c=13.5688(2)Å
α=85.3750(10)° β=83.9590(10)° γ=83.8070(10)°